High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis
The DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This is concerning given the established evidence of increased depression, anxiety, eating disorders and other mental illnesses in those affected with PCOS [3, 8, 57–59].”
From Challenges in diagnosis and health care in polycystic ovary syndrome in Canada: a patient view to improve health care (2023) · cites this paper as [58]
In the citing paper
“This prevalence of eating disorders is relatively high compared to that found in other population studies that report a 0.3%-2.45% prevalence in those with PCOS.31,126,129,130”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [129]
In the citing paper
“Another meta-analysis estimated a prevalence of 36 % for depression in PCOS [69].”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [69]
In the citing paper
“The risk of developing depression may be associated with higher BMI [70], although this association is weak.”
From Providing lifestyle advice to women with PCOS: an overview of practical issues affecting success (2021) · cites this paper as [70]
In the citing paper
“A recent meta-analysis of depression rates among women with PCOS resulted in a median prevalence of depression of almost 37% compared to 14% in controls [8].”
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Cohen, J. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.1.155 · Cited by 8,771
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Depression and Type 2 Diabetes Over the Lifespan
Mezuk, B., Eaton, W. W., Albrecht, S., & Golden, S. H. (2008) · Diabetes Care · doi:10.2337/dc08-0985 · Cited by 1,558
Bozdag, G., Mumusoglu, S., Zengin, D., Karabulut, E., & Yildiz, B. O. (2016) · Human Reproduction · doi:10.1093/humrep/dew218 · Cited by 1,526
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Research works printed but not linked: 3
- 2014, Body image, self-esteem and depressive symptomatology in women with polycystic ovary syndrome, Noropsikiyatri Arsivi, 51, 129
- 2013, Psychiatric symptoms in women with polycystic ovary syndrome, Dusunen Adam, 26, 157
- 1992, Polycystic ovary syndrome, 377
Cited by
Items 201–300 of 750
Systematic review of sex differences in the relationship between hormones and depression in HIV
Turk, M. C., Bakker, C., Spencer, S. M., & Lofgren, S. M. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105665 · Cited by 20
Sukhapure, M., Eggleston, K., Fenton, A. J., FRAMPTON, C. M. A., Porter, R., & Douglas, K. M. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s385014 · Cited by 19
Cao, Y., Li, G., & Ren, Y. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02222-5 · Cited by 19
Dutkowska, A., Konieczna, A., Breska-Kruszewska, J., Krzyczkowska-Sendrakowska, M., Kowalska, I., & Rachoń, D. (2019) · Endokrynologia Polska · doi:10.5603/ep.a2019.0006 · Cited by 19
Boivin, M. J., Fatehi, F., Phillips-Chan, A. E., Richardson, J., Summers, A. N., & Foley, S. A. (2020) · BMC Women s Health · doi:10.1186/s12905-020-00994-8 · Cited by 19
Diagnosis and Treatment of Polycystic Ovary Syndrome in Adolescent Females
Ebersole, A. M., & Bonny, A. E. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000538 · Cited by 19
Mental health and body image in polycystic ovary syndrome.
Lee, I., & Dokras, A. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.04.004 · Cited by 18
Self-citationPerceived stress scale among adolescents with polycystic ovary syndrome
Khafagy, G., El Sayed, I., Abbas, S., & Soliman, S. (2020) · International Journal of Women's Health · doi:10.2147/ijwh.s279245 · Cited by 18
Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome
Yang, Y., Liu, L., Hu, N., Huo, H., Yang, X., & Wang, F. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1520641 · Cited by 18
Harnod, T., Chen, W., Wang, J.-H., Lin, S., & Ding, D. (2019) · Human Reproduction · doi:10.1093/humrep/dez081 · Cited by 18
Akintoye, O. O., Ajibare, A. J., Oriyomi, I. A., Olofinbiyi, B. A., Oyiza, Y. G., Afuye, D. C., Babalola, K. T., Faturoti, O. E., Oludipe, S. I., & Owoyele, V. B. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121737 · Cited by 18
The prevalence of anxiety in adult endocrinology outpatients: A systematic review and meta–analysis
Kershaw, K. A., Storer, B., Braund, T. A., Chakouch, C., Coleshill, M. J., Haffar, S., Harvey, S. B., Newby, J. M., Sicouri, G., & Murphy, M. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106357 · Cited by 18
Gut bacteriome and mood disorders in women with PCOS
Lee, S., Tejesvi, M. V., Hurskainen, E., Aasmets, O., Plaza‐Díaz, J., Franks, S., Morin-Papunen, L. C., Tapanainen, J. S., Ruuska, T. S., Altmäe, S., et al. (2024) · Human Reproduction · doi:10.1093/humrep/deae073 · Cited by 18
Wang, G., Liu, X., Zhu, S., & Lei, J. (2024) · Journal of Advanced Nursing · doi:10.1111/jan.16220 · Cited by 18
Kataoka, J., Olsson, M., Lindgren, E., Larsson, I., Schmidt, J., Benrick, A., & Stener‐Victorin, E. (2024) · Scientific Reports · doi:10.1038/s41598-024-63166-w · Cited by 18
How to Evaluate Acne in Reproductive-Age Women: An Epidemiological Study in Chinese Communities
Wang, Y., Li, S., LUO, S. H., Qin, L., Zeng, X., Li, L., & Li, X.-H. (2019) · BioMed Research International · doi:10.1155/2019/6126808 · Cited by 18
Mezzullo, M., Fanelli, F., Dalmazi, G. D., Fazzini, A., Gasparini, D. I., Mastroroberto, M., Guidi, J., Morselli‐Labate, A. M., Pasquali, R., Pagotto, U., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.022 · Cited by 18
Khan, F., Govender, N., Mitha, S. B., & Thandar, Y. (2026) · Archives of Women s Mental Health · doi:10.1007/s00737-025-01636-4 · Cited by 17
Hu, R., Geng, Y., Huang, Y., Liu, Z., Li, F., Dong, H., Ma, W., Song, K., Zhang, M., Zhang, Z., et al. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14988 · Cited by 17
Noguchi, H., Iwasa, T., Iwase, A., Kanasaki, H., Kimura, F., Kugu, K., Saito, K., Baba, T., Hara, T., & Matsuzaki, T. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15972 · Cited by 17
Treatment and complications of PCOS in adolescents - what’s new in 2023?
Jakubowska-Kowal, K. M., Skrzyńska, K., & Gawlik, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1436952 · Cited by 17
The current landscape of mental health challenges in women with PCOS: a narrative review
Khan, F., Govender, N., & Thandar, Y. (2025) · Current Psychology · doi:10.1007/s12144-025-07435-5 · Cited by 17
Franik, G., Krysta, K., Witkowska, A., Dudek, A. Z., Krzystanek, M., & Madej, P. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1613359 · Cited by 17
Scannell, N., Moran, L., Mantzioris, E., Cowan, S., & Villani, A. M. (2022) · Metabolites · doi:10.3390/metabo12040311 · Cited by 17
Donbaloğlu, Z., Tuhan, H., Çoban, Ö. G., Kızılay, D. Ö., İsmailoğlu, E., Önder, A., Acar, S., Bedel, A., Çetiner, E. B., Singin, B., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0010 · Cited by 17
Rate of polycystic ovary syndrome in mental health disorders: a systematic review
Douglas, K. M., Fenton, A. J., Eggleston, K., & Porter, R. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01179-4 · Cited by 17
Polycystic Ovary Syndrome (PCOS) and Non-Suicidal Self-Injury (NSSI): A Community-Based Study
Williams, S., Fido, D., & Sheffield, D. (2022) · Healthcare · doi:10.3390/healthcare10061118 · Cited by 17
Cowan, S., Grassi, A., Monahan Couch, L., Jeanes, Y., Lim, S., Pirotta, S., Harris, J., McGirr, C., & Moran, L. (2023) · Nutrients · doi:10.3390/nu15030589 · Cited by 16
Htet, T., Cassar, S., Kuczynska-Burggraf, M., Gibson-Helm, M., Chiu, W.-L., Stepto, N., Moran, L., & Boyle, J. (2018) · Seminars in Reproductive Medicine · doi:10.1055/s-0038-1667309 · Cited by 16
Senthilkumar, H., Chauhan, S. C., & Arumugam, M. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11081-2 · Cited by 16
Zhou, X. P., Greenwood, E. A., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2021) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.9372 · Cited by 16
Reproduction as a window to future health in women
Huttler, A., Murugappan, G., Stentz, N. C., & Cedars, M. I. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.005 · Cited by 16
Wang, G., Liu, X., & Lei, J. (2023) · The Journal of Psychology · doi:10.1080/00223980.2023.2283472 · Cited by 16
Serum klotho as a novel biomarker for metabolic syndrome: findings from a large national cohort
Li, Y., Chang, Y., Chen, N., Zhao, Y., Zhang, X., Song, W., Lu, J., & Liu, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1295927 · Cited by 16
Intertwined reproductive endocrinology: Puberty and polycystic ovary syndrome
Witchel, S. F., & Plant, T. M. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.07.004 · Cited by 16
Different sleep pattern in over-weight/obese women with polycystic ovary syndrome
Öberg, E., Blomberg, L., Åkerstedt, T., & Hirschberg, A. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1068045 · Cited by 15
Chang, H., Shi, B., Ge, H., Liu, C., Wang, L., Ma, C., Liu, L., Zhang, W., Zhang, D., Wang, Y. L., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1237260 · Cited by 15
Tseng, P., Chiu, H., Tu, C., Wu, M., Ho, H., & Chen, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.779456 · Cited by 15
Donaldson, L., Dezard, V. A., Chen, M., & Margolin, E. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120120 · Cited by 15
Depression symptoms and quality of life in women with polycystic ovary syndrome
Koçak, D. Y., & Uğurlu, M. (2022) · Perspectives In Psychiatric Care · doi:10.1111/ppc.13131 · Cited by 15
Depressive Symptoms and Control of Emotions among Polish Women with Polycystic Ovary Syndrome
Pokora, K., Kowalczyk, K., Wikarek, A., Rodak, M., Pędrys, K., Wójtowicz, M., Wyskida, K., & Jonderko, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416871 · Cited by 14
“Especially hirsutism, which is a clinical manifestation of hyperandrogenism, may be associated with an increased occurrence of depression [33].”
BackgroundEEG-ERP Correlates of Cognitive Dysfunction in Polycystic Ovarian Syndrome
Showkath, N., Sinha, M., Ghate, J. R., Agrawal, S., Mandal, S., & Sinha, R. (2022) · Annals of Neurosciences · doi:10.1177/09727531221115318 · Cited by 14
Donaldson, N. M., Prescott, M., Ruddenklau, A., Campbell, R. E., & Desroziers, E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1116482 · Cited by 14
The modern pathogenetic challenges of polycystic ovary syndrome
Pakharenko, L. V., Zhylka, N. Y., Shcherbinska, O. S., Kravchuk, I. V., Lasytchuk, O. M., Zhurakіvskyi, V. M., & Kaminskyi, V. (2024) · Reproductive health of woman · doi:10.30841/2708-8731.2.2024.304662 · Cited by 14
PCOS - the many faces of a disorder in women and men
Lafcı, N. G., Yılmaz, B., & Yıldız, B. O. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02512-1 · Cited by 14
Assessment of Optimism in Women with Polycystic Ovary Syndrome: A Case Control-Study
Morán‐Sánchez, I., Adoamnei, E., Sánchez-Ferrer, M. L., Prieto‐Sánchez, M. T., Árense-Gonzalo, J. J., Carmona‐Barnosi, A., Peñalver, A. I. H., Mendiola, J., & Torres-Cantero, A. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18052352 · Cited by 14
Dutkiewicz, E., Rachoń, D., Dziedziak, M., Kowalewska, A., & Moryś, J. M. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01500-x · Cited by 14
Vishnubotla, D. S., Tenali, S. N., Fernandez, M., & Madireddi, S. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_467_21 · Cited by 14
Unfer, V., Lepore, E., Forte, G., Marín, I. H., Wdowiak, A., & Pkhaladze, L. (2025) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07897-1 · Cited by 13
An endocrinological perspective on polycystic ovarian syndrome
Basak, S., Dixit, A. K., Dey, R. K., Puia, L., Bora, M., Yr, S. K., & Babu, G. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112524 · Cited by 13
Nandi, A., Singh, K. D., & Sharma, K. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07187-w · Cited by 13
Soltaninejad, F., Shafiei, G., Rafie, F., Nematollahi‐Mahani, S. N., Pourjafari, F., Haghpanah, T., & Afarinesh, M. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-09264-9 · Cited by 13
Atinga, A., Bashiru, H. A., Solomon, A. O., Oghide, O., Adufe, I., Aduroja, P. E., Afolabi, A. O., Bakare, A. A., Olabisi, O. I., Mshelia, P. P., et al. (2025) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2025.1688913 · Cited by 13
Abu‐Zaid, A., Bhagavathula, A. S., Rahmani, J., Alyoubi, R. A., Alomar, O., Baradwan, S., Alkhamis, W. H., Khalifa, M., Alshahrani, M. S., Khadawardi, K. A., et al. (2022) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2022.2040983 · Cited by 13
Zhang, Z., Liu, M., Zhao, F., Chen, H., & Chen, X. (2024) · Cureus · doi:10.7759/cureus.70352 · Cited by 13
Lindheim, L., Manti, M., Fornes, R., Bashir, M., Czarnewski, P., Diaz, O. E., Seifert, M., Engstrand, L. G., Villablanca, E. J., Obermayer-Pietsch, B. M., et al. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00266 · Cited by 13
The Polycystic Ovary Syndrome (PCOS)
Louwers, Y. V., & Laven, J. S. E. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_3-1 · Cited by 13
Marasca, C., Fabbrocini, G., Barrea, L., Capasso, G., Guida, A. D., Cinelli, E., & Fontanella, G. (2021) · Minerva Endocrinology · doi:10.23736/s0391-1977.20.03248-4 · Cited by 13
Luque‐Ramírez, M., Ortiz-Flores, A. E., Nattero‐Chávez, L., & Escobar-Morreale, H. F. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1839409 · Cited by 13
Lee, I. O., Kim, J. C., Seo, J. W., Pak, H. Y., & Chung, J. E. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1849071 · Cited by 13
Self-citationPolycystic Ovary Syndrome Can Lead to Neurocognitive Changes in Female Rats Treated with Letrozole
Mohammadi, M., Fatemi, I., Taghipour, Z., Azin, M., Kaeidi, A., Hakimizadeh, E., Taghizadeh, R., & Hassanipour, M. (2021) · Archives of Neuroscience · doi:10.5812/ans.112023 · Cited by 13
Zhou, J. W., Yang, L., Yu, J., Wang, Y., & Liu, Z. (2017) · Medicine · doi:10.1097/md.0000000000008828 · Cited by 13
Beyond counting sheep: Exploring the link between polycystic ovary syndrome and sleep health
Jafar, N. K. A., Bennett, C. J., Moran, L. J., & Mansfield, D. R. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777724 · Cited by 12
Percy, C., Turner, A., & Orr, C. (2024) · JMIR Formative Research · doi:10.2196/52427 · Cited by 12
Scannell, N., Mantzioris, E., Rao, V. S., Pandey, C., Ee, C., Mousa, A., Moran, L., & Villani, A. M. (2023) · Biomedicines · doi:10.3390/biomedicines11123349 · Cited by 12
Hong, Z., Wu, P., Zhuang, H., Chen, L., Hong, S., & Qin, J. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06378-8 · Cited by 12
Gul, O. K., Akkuş, M., & Akkuş, F. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03930-w · Cited by 12
Polycystic Ovary Syndrome in Active Duty Service Women: A Retrospective Analysis
Hopkins, D., & Wilson, C. (2019) · Military Medicine · doi:10.1093/milmed/usz023 · Cited by 12
Circulating steroids and mood disorders in patients with polycystic ovary syndrome
Yoshida, T., Saito, K., Kawamura, T., Ishikawa, T., Kato, T., Matsubara, K., Miyasaka, N., Miyado, M., & Fukami, M. (2020) · Steroids · doi:10.1016/j.steroids.2020.108748 · Cited by 12
Mushtaq, A., Bibi, A., & Kausar, N. (2022) · Pakistan Journal of Zoology · doi:10.17582/journal.pjz/20210919130943 · Cited by 12
Kaushik, S., Ahmad, F., Choudhary, S., Mathkor, D. M., Mishra, B. N., Singh, V., & Haque, S. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105270 · Cited by 12
Jiskoot, G., Somers, S., Roo, C. D., Stoop, D., & Laven, J. S. E. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12123927 · Cited by 12
Considerations in the Treatment of Depression and Anxiety in Women with PCOS
Alur-Gupta, S., & Dokras, A. (2023) · Seminars in Reproductive Medicine · doi:10.1055/s-0043-1777720 · Cited by 12
Self-citationTwelve-month Continuation of the Etonogestrel Implant in Adolescents With Polycystic Ovary Syndrome
Buyers, E. M., Sass, A. E., Severn, C., Pyle, L. L., & Cree‐Green, M. (2020) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2020.08.017 · Cited by 12
Piotrowska, A., Pilch, W., Czerwińska‐Ledwig, O., Zuziak, R., Siwek, A., Wolak, M., & Nowak, G. (2019) · Biological Trace Element Research · doi:10.1007/s12011-019-1654-5 · Cited by 12
Zhang, J., Tang, L., Kong, L., Wu, T., Xu, L., Pan, X., & Liu, G. J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008583.pub2 · Cited by 12
Scannell, N., Villani, A., Moran, L., & Mantzioris, E. (2025) · Proceedings of the Nutrition Society · doi:10.1017/s0029665124007584 · Cited by 12
“Women with PCOS have a heightened prevalence of depression (2.3-fold) and anxiety (4-fold) compared to those without PCOS (15) .”
InfluentialWang, J., Fiori, P. L., Capobianco, G., Carru, C., & Chen, Z. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1275419 · Cited by 11
Jannink, T. I., Bordewijk, E. M., Lehmann, V., Hoek, A., Goddijn, M., & van Wely, M. (2025) · Human Reproduction · doi:10.1093/humrep/deaf214 · Cited by 11
How Will the New Global Polycystic Ovary Syndrome Guideline Change Our Clinical Practice?
Jacob, S., & Balen, A. H. (2019) · Clinical Medicine Insights Reproductive Health · doi:10.1177/1179558119849605 · Cited by 11
Li, X., Cui, T., Song, X., Tian, W., Lin, Y., & Zhang, H. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.02.014 · Cited by 11
Piccini, C. D., Michelon, E. D. S., Medeiros, A. G., Heinen, C. A., Maranghelli, G. S., & Corleta, H. V. E. (2021) · Clinical & Biomedical Research · doi:10.22491/10.22491/2357-9730.107691 · Cited by 11
Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs
Cardozo, L. L. Y., & Romero, D. G. (2021) · The FASEB Journal · doi:10.1096/fj.202002526rr · Cited by 11
The Relationship Between Mood and Sleep in Different Female Reproductive States
Polo‐Kantola, P., & Toffol, E. (2023) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2023.06.002 · Cited by 11
Kwiatkowski, J., Akpang, N., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157525 · Cited by 10
Polycystic ovary syndrome: An update on diagnosis and management
Sung, N., Amir, J., Alwahab, U. A., & Falcone, T. (2026) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.93a.25090 · Cited by 10
Le syndrome des ovaires polykystiques : quelles nouveautés en 2019 ?
Gourbesville, C., Kerlan, V., & Reznik, Y. (2019) · Annales d Endocrinologie · doi:10.1016/s0003-4266(19)30114-3 · Cited by 10
Li, R., Ma, C., Xiong, Y., Zhao, H., Yang, Y., Li, X., Wang, B., Xiao, T., Chen, J., Lei, X., et al. (2021) · Biomolecules · doi:10.3390/biom11060857 · Cited by 10
Glintborg, D., Petersen, T. G., Rubin, K. H., & Andersen, M. (2022) · Biomedicines · doi:10.3390/biomedicines10102396 · Cited by 10
Wang, G., Liu, X., & Lei, J. (2023) · Journal of Health Psychology · doi:10.1177/13591053231186916 · Cited by 10
Pastoor, H., Both, S., Timman, R., Laan, E. T. M., & Laven, J. S. E. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.07.002 · Cited by 10
Scannell, N., Mantzioris, E., Cowan, S., Moran, L., & Villani, A. M. (2025) · Proceedings of The Nutrition Society · doi:10.1017/s0029665126104054 · Cited by 9
Huddleston, H. G., Casaletto, K. B., Greenwood, E. A., Rasgon, N., Maki, P. P., Cedars, M. I., & Pasch, L. A. (2022) · F&S Reports · doi:10.1016/j.xfre.2022.08.008 · Cited by 9
Silva, I. S. T., Costa, A. L. M. L., Araújo, H. F. D. A., Soares, L. L., Ribeiro, M. J. A., Araújo, R. F. D. A., dos Santos, T. N. B., Leão, T. L. D. O., & Lopes, A. G. (2020) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e3909.2020 · Cited by 9
Ding, N., Yue, R., Wang, L., & Yang, H. (2020) · Medicine · doi:10.1097/md.0000000000022982 · Cited by 9
Zhang, J., Tang, L., Kong, L., Wu, T., Xu, L., Pan, X., & Liu, G. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008583.pub3 · Cited by 9
Görkem, Ü., & Yildirim, E. O. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15176 · Cited by 9
The Polycystic Ovary Syndrome (PCOS)
Louwers, Y. V., & Laven, J. S. E. (2020) · Endocrinology · doi:10.1007/978-3-030-14782-2_3 · Cited by 9
McIlvenna, L. C., Altıntaş, A., Patten, R. K., McAinch, A. J., Rodgers, R. J., Stepto, N. K., Barrès, R., & Moreno‐Asso, A. (2022) · The Journal of Physiology · doi:10.1113/jp282954 · Cited by 9
Sherif, K., Coborn, J., Hoovler, A., & Gill, L. A. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2140511 · Cited by 9
Metadata
- Authors
- Cooney, L. G., Lee, I., Sammel, M. D., & Dokras, A.
- Affiliations
- Hospital of the University of Pennsylvania (US)
- Corresponding author
- Cooney, Laura G.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-03-09
- Volume
- 32
- Issue
- 5
- Pages
- 1075-1091
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2592269563
- Cited by
- 631
- References
- 80
- Citations by year
- 2026: 95 · 2025: 94 · 2024: 63 · 2023: 81 · 2022: 70 · 2021: 77 · 2020: 56 · 2019: 49 · 2018: 35 · 2017: 10
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- polycystic ovary syndrome, depressive symptoms, anxiety symptoms, depression prevalence, anxiety prevalence, obesity, insulin resistance, testosterone, hirsutism, body mass index, age, women's mental health, comorbidities, Rotterdam criteria, NIH criteria, screening tool, meta-regression, standardized mean difference
- MeSH terms
- Anxiety, Depression, Female, Humans, Polycystic Ovary Syndrome, Severity of Illness Index, Comorbidity, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.